Agilent Automation Announces Presence at SBS
News Apr 09, 2009
Agilent Automation Solutions, formerly Velocity11, has announced that it will present its latest automated solutions for drug discovery, target biology and stem cell therapeutics, at the 15th Annual SBS Conference & Exhibition in Lille (France).
Making its European debut on Booth 204 will be the Agilent Direct Drive Robot (DDR) - a revolutionary new system that uses configurable Z-travel technology to enable stacking of instruments and more functionality in a smaller footprint. One-person, one-touch teaching enables easy configuration.
In addition, Agilent Automation Solutions will be exhibiting its new generation VWorks Automation Control Software plus several workstations highlighting the BenchCel and Bravo automation platforms demonstrating new application developments in compound management, ADMET and genomics.
For laboratories looking to ensure maximum throughput and optimal resource utilization - Agilent will present a free tutorial entitled 'Increase walk-away time, speed and reliability in a fully automated multiplex ELISA assay platform'. This tutorial will cover new features of VWorks software in a multiplex ELISA assay that allows for more productive time and increased quality of the data.
Running simultaneous protocols the system allows utilization of multiple readers and parallel plate processing, while the new time constraints feature enables control of timing between tasks in time critical ELISA assays. A system state editor simplifies recovery from deadlocks in complex multiplex assay protocols and a new error library feature reduces number of interruptions and human intervention.
A poster entitled 'Automated High Content Screening of small molecules for Muscular Dystrophy therapeutic research' by researchers at I-STEM (Evry, France) and Agilent Automation Solutions will describe pioneering work carried out using a novel automated stem cell high content screening platform.
From stand-alone units to fully integrated systems, Agilent Automation Solutions teams key sample preparation and creative walk-away automation approaches with personalized customer service to provide complete solutions for your laboratory. Combining engineering with high standards of quality, Agilent designs and manufactures high-performance equipment for processes that are revolutionizing pharmaceutical, biotech, and genomic research.
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE